Total Payments
$16,373
2024 Payments
$2,380
Companies
78
Transactions
727
Medicare Patients
5,878
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$13,299 (81.2%)
Other$2,500 (15.3%)
Consulting$525.00 (3.2%)
Education$49.10 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,299 | 722 | 81.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 1 | 15.3% |
| Consulting Fee | $525.00 | 1 | 3.2% |
| Education | $49.10 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Rigel Pharmaceuticals, Inc. | $2,828 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,238 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,123 | 37 | $0 (2024) |
| PFIZER INC. | $1,024 | 64 | $0 (2024) |
| Celgene Corporation | $810.45 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $619.70 | 36 | $0 (2024) |
| Genentech USA, Inc. | $608.51 | 38 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $569.58 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $508.41 | 41 | $0 (2024) |
| Amgen Inc. | $497.98 | 24 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,380 | 116 | Novartis Pharmaceuticals Corporation ($329.49) |
| 2023 | $2,762 | 113 | AstraZeneca Pharmaceuticals LP ($617.09) |
| 2022 | $2,944 | 150 | Genentech USA, Inc. ($188.08) |
| 2021 | $1,316 | 85 | Novartis Pharmaceuticals Corporation ($231.35) |
| 2020 | $682.26 | 46 | AstraZeneca Pharmaceuticals LP ($81.85) |
| 2019 | $4,252 | 107 | Rigel Pharmaceuticals, Inc. ($2,614) |
| 2018 | $1,087 | 64 | PFIZER INC. ($230.92) |
| 2017 | $950.15 | 46 | Amgen Inc. ($128.59) |
All Payment Transactions
727 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.11 | General |
| 12/13/2024 | Genentech USA, Inc. | Itovebi (Biological), Phesgo, Polivy | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: BioOncology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Oncology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Oncology | ||||||
| 12/02/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $0.70 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Hematology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Oncology | ||||||
| 11/15/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Oncology | ||||||
| 11/09/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $18.92 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $29.39 | General |
| 11/05/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 10/09/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $15.77 | General |
| 10/01/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Oncology | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 555 | 1,053 | $281,079 | $75,327 |
| 2022 | 10 | 664 | 1,222 | $333,278 | $89,697 |
| 2021 | 42 | 2,320 | 75,460 | $1.5M | $441,114 |
| 2020 | 43 | 2,339 | 87,462 | $2.8M | $859,564 |
Total Patients
5,878
Total Services
165,197
Medicare Billing
$1.5M
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 169 | 438 | $111,252 | $28,598 | 25.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 66 | 143 | $49,049 | $14,090 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 128 | 188 | $32,336 | $7,573 | 23.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 47 | 120 | $21,000 | $6,848 | 32.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 51 | $25,092 | $6,197 | 24.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 44 | 44 | $21,648 | $5,760 | 26.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 36 | $9,108 | $3,230 | 35.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 22 | $7,304 | $1,996 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $4,290 | $1,036 | 24.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 204 | 497 | $126,374 | $33,056 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 93 | 222 | $76,295 | $22,608 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 162 | 230 | $39,560 | $9,086 | 23.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 66 | 66 | $32,472 | $8,505 | 26.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 50 | $24,600 | $7,196 | 29.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 84 | $14,700 | $4,291 | 29.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 27 | $6,831 | $1,822 | 26.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,980 | $1,452 | 29.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $5,460 | $1,188 | 21.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 17 | $2,006 | $494.68 | 24.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 12 | 5,400 | $199,800 | $89,464 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 231 | 591 | $166,662 | $53,570 | 32.1% |
| 78815 | Nuclear medicine study with ct imaging skull base to mid-thigh | Office | 2021 | 41 | 46 | $161,000 | $47,345 | 29.4% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2021 | 38 | 44,370 | $88,740 | $33,625 | 37.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 44 | 338 | $139,594 | $33,473 | 24.0% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 14 | 4,260 | $102,240 | $28,893 | 28.3% |
About Dr. Vijay Raghavan, MD
Dr. Vijay Raghavan, MD is a Hematology & Oncology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316948995.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vijay Raghavan, MD has received a total of $16,373 in payments from pharmaceutical and medical device companies, with $2,380 received in 2024. These payments were reported across 727 transactions from 78 companies. The most common payment nature is "Food and Beverage" ($13,299).
As a Medicare-enrolled provider, Raghavan has provided services to 5,878 Medicare beneficiaries, totaling 165,197 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Louisville, KY
- Active Since 08/09/2005
- Last Updated 10/13/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1316948995
Products in Payments
- Tavalisse (Drug) $2,750
- CALQUENCE (Drug) $619.83
- KEYTRUDA (Biological) $605.14
- KISQALI (Drug) $364.92
- BRUKINSA (Drug) $337.71
- Lenvima (Drug) $324.10
- OPDIVO (Biological) $323.31
- XTANDI (Drug) $312.44
- ELIQUIS (Drug) $279.60
- Pomalyst (Drug) $274.93
- REBLOZYL (Biological) $265.29
- Enhertu (Drug) $252.78
- IMBRUVICA (Drug) $246.61
- IBRANCE (Drug) $238.70
- LIBTAYO (Biological) $235.39
- PADCEV (Biological) $211.31
- MEKINIST (Drug) $207.34
- DARZALEX (Biological) $184.71
- FOTIVDA (Drug) $166.09
- clonoSEQ (Device) $164.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Louisville
Goetz Kloecker, Md, MD
Hematology & Oncology — Payments: $761,985
Hematology & Oncology $761,985
Vivek Sharma, Md, MD
Hematology & Oncology — Payments: $594,741
Hematology & Oncology $594,741
Dr. Khuda Khan, M.d., Ph.d, M.D., PH.D
Hematology & Oncology — Payments: $446,138
Hematology & Oncology $446,138
Dr. Jeffrey Hargis, M.d, M.D
Hematology & Oncology — Payments: $430,805
Hematology & Oncology $430,805
Dr. Joseph Maly, M.d, M.D
Hematology & Oncology — Payments: $43,035
Hematology & Oncology $43,035
Dr. Emmanuel Nidhiry, M.d, M.D
Hematology & Oncology — Payments: $40,629
Hematology & Oncology $40,629